Animab is excited to announce a major milestone in our journey to revolutionize animal production—we have successfully raised $11,760,000 in our latest round of funding. This significant investment is a testament to the confidence our investors have in our innovative approach and the transformative potential of our technology. At Animab, we are dedicated to addressing the evolving needs of animal production by harnessing breakthrough research in gut science and biotechnology. Our proprietary discoveries have paved the way for a novel range of solutions in animal health, enhanced cost efficiencies, and improved sustainability, setting us apart in an industry ripe for disruption. The funds raised will enable us to accelerate product development and expand our research initiatives, ensuring we stay at the forefront of interdisciplinary innovation by integrating advanced animal science, cutting-edge research, and biotechnology. Our seasoned team—comprising experts in vaccines, business management, international marketing, and a host of relevant domains—remains committed to delivering solutions that offer a safer, more sustainable path to optimal animal performance. We plan to invest in scaling our operations, fortifying our market presence, and forging key partnerships that will further our mission of delivering effective, science-based breakthroughs for animal production worldwide. The support from our investors not only fuels our immediate growth objectives but also solidifies our long-term commitment to sustainable animal agriculture. For more information on our innovative journey and upcoming initiatives, please visit www.animab.com.












